Tamoxifen Fails to Deliver on Clinical Promise for Duchenne Muscular Dystrophy
(MedPage Today) -- Repurposed tamoxifen failed to delay disease progression as an adjunct to corticosteroids among boys with Duchenne muscular dystrophy (DMD), the phase III TAMDMD trial showed.
In an intention-to-treat population, no significant...
Source: MedPage Today Neurology - Category: Neurology Source Type: news
More News: Boys | Brain | Corticosteroid Therapy | Muscular Dystrophy | Neurology | Reflex Sympathetic Dystrophy | Tamoxifen